| 产品名称: | SNU-C2B |
|---|---|
| 商品货号: | TS210873 |
| Organism: | Homo sapiens, human |
| Tissue: | cecum |
| Product Format: | frozen |
| Morphology: | epithelial |
| Culture Properties: | loosely adherent, multicell aggregates |
| Biosafety Level: | 1
Biosafety classification is based on U.S. Public Health Service Guidelines, it is the responsibility of the customer to ensure that their facilities comply with biosafety regulations for their own country. |
| Disease: | colorectal carcinoma |
| Age: | 43 years |
| Gender: | female |
| Ethnicity: | Asian |
| Applications: | This is one of 14 colorectal carcinoma cell lines derived by J.G. Park and associates during the years 1982 through 1985. The line was obtained from a fourth passage nude mouse xenograft of tumor fragments obtained from a patient prior to therapy (see also TS210873.1 which was derived from the third nude mouse passage). |
| Storage Conditions: | liquid nitrogen vapor phase |
| Karyotype: | modal number = 46; range = 45 to 48. This is a pseudodiploid human cell line. The modal chromosome number is 46, occurring at 70% with polyploidy at 16.4%. The del (3) (p23), t(4,?), t(8;?) (p22), del (9) (p13), del (11) (p13), t(1;8) (p13;p24), t(1;?) (q11;?) and 2 other marker chromosomes are common to all metaphases examined. Other structurally altered chromosomes, if any, occur only sporadically. The t(1;8) and t(1;?) are not found in CCL-250.1. Normal N8 and N11 are absent. The X chromosomes are two copies per cell. The Y chromosome is not detected by Q-banding. |
| Derivation: | This is one of 14 colorectal carcinoma cell lines derived by J.G. Park and associates during the years 1982 through 1985. The line was obtained from a fourth passage nude mouse xenograft of tumor fragments obtained from a patient prior to therapy (see also TS210873.1 which was derived from the third nude mouse passage). |
| Clinical Data: | female
Asian
43 years |
| Antigen Expression: | Blood type A; Rh+ |
| Receptor Expression: | epidermal growth factor (EGF) |
| Genes Expressed: | carcinoembryonic antigen (CEA), 24 ng/ml per 10 exp6 cells per 10 days,Blood type A; Rh+ |
| Cellular Products: | carcinoembryonic antigen (CEA), 24 ng/ml per 10 exp6 cells per 10 days |
| Tumorigenic: | Yes |
| Effects: | Yes, in nude mice (Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 10(7) cells) |
| Comments: | The cells have a high concentration of receptors for EGF. Note that this line has lost both chromosomes 8 and 11 while SNU-C2A (TS210873.1) has lost only chromosome 11. Tumors developed within 21 days at 100% frequency (5/5) in nude mice inoculated subcutaneously with 107 cells |
| Complete Growth Medium: | The base medium for this cell line is ATCC-formulated RPMI-1640 Medium, ATCC 30-2001. To make the complete growth medium, add the following components to the base medium: fetal bovine serum (ATCC 30-2020) to a final concentration of 10%.
|
| Subculturing: |
Medium Renewal: 2 to 3 times per week |
| Cryopreservation: | Freeze medium: Complete growth medium supplemented with 5% DMSO Storage temperature: liquid nitrogen vapor phase |
| Culture Conditions: | Temperature: 37°C |
| STR Profile: | Amelogenin: X
CSF1PO: 11, 14
D13S317: 9, 10, 11
D16S539: 8, 9
D5S818: 8, 9
D7S820: 13, 16
THO1: 9
TPOX: 8
vWA: 15, 18, 19
Species confirmation via CO1 assay: Human (mouse material may also be detected, likely due to this cell line being a nude mouse xenograft of tumor fragments from a human patient) |
| Isoenzymes: | AK-1, 1 ES-D, 1 G6PD, B GLO-I, 2 Me-2, 2 PGM1, 1 PGM3, 1 |
| Name of Depositor: | AF Gazdar |
| Deposited As: | Homo sapiens |
| Passage History: | The line was obtained from a fourth passage nude mouse xenograft of tumor fragments obtained from a patient prior to therapy (see also TS210873.1 which was derived from the third nude mouse passage). |
| Year of Origin: | 1982 |
| References: | Park JG, et al. Characteristics of cell lines established from human colorectal carcinoma. Cancer Res. 47: 6710-6718, 1987. PubMed: 3479249 |